Delivery Order SPE2DB24D2208-SPE2DB25FHGUK

Award Date 11/19/24
Potential Completion Date 11/20/24
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D2208
    Indefinite Delivery Contract
  • SPE2DB24D2208-SPE2DB25FHGUK
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $8,211.16, is for the delivery of 4,566,490,410 units of the medication Candesartan Cilexetil 16 mg tablets. The contract has a delivery order structure and a firm fixed price pricing type, with a period of performance running through November 20, 2024. This award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/18/25, 1:39 PM